Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody.

The objective of this study was to assess apoptotic activity in gestational trophoblastic disease (GTD) and its prognostic value in hydatidiform mole (HM).
Expression of the specific caspase cleavage site within cytokeratin 18 was assessed immunohistochemically using the monoclonal antibody M30 CytoDeath in 12 spontaneous abortions, 22 partial and 57 complete HM, eight choriocarcinoma (CCA) and 28 normal placentas. The M30 immunoreactivity occurred predominantly in the syncytiotrophoblasts. A significantly higher M30 index in HM and CCA was found when compared with normal placentas and spontaneous abortions (P < 0.001). The M30 index of those HM which spontaneously regressed was significantly higher than those HM which developed persistent disease requiring chemotherapy (P < 0.001). The M30 index correlated with another apoptotic index previously detected by TdT-mediated dUTP nick-end labelling (TUNEL) (P = 0.007) and the proliferation index assessed by the Ki67 antigen (P = 0.034).
We conclude that apoptosis is important in the pathogenesis of GTD. Assessment of apoptotic activity in HM by the M30 index may be considered as an alternative prognostic indicator for predicting the clinical behaviour.
AuthorsP M Chiu, Y S Ngan, U S Khoo, A N Cheung
JournalHistopathology (Histopathology) Vol. 38 Issue 3 Pg. 243-9 (Mar 2001) ISSN: 0309-0167 [Print] England
PMID11260306 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Keratins
  • Caspases
  • Abortion, Spontaneous (metabolism)
  • Apoptosis
  • Caspases (metabolism)
  • Choriocarcinoma (metabolism)
  • Female
  • Follow-Up Studies
  • Humans
  • Hydatidiform Mole (metabolism, pathology)
  • In Situ Nick-End Labeling
  • Keratins (metabolism)
  • Pregnancy
  • Prognosis
  • Trophoblastic Neoplasms (metabolism, pathology)
  • Trophoblastic Tumor, Placental Site (metabolism, pathology)
  • Uterine Neoplasms (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: